Therese Liechtenstein is an Investment Director at 4BIO Capital, whose known portfolio counts 9 companies.
Is Therese Liechtenstein a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechCellular TherapyDiagnosticsDrug DiscoveryGene TherapyGenomicsMedTechMicrobiomePharma
Contacts
Affiliated funds' portfolios
Investment Director at 4BIO Capital, whose known portfolio counts 9 companies
- Ray Therapeutics
- Trogenix
- Actithera
- March Biosciences
- ViaNautis
- Ascend Gene & Cell Therapies
- Redpin Therapeutics
- Cytospire Therapeutics
- Hornet Therapeutics
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Cellular Therapy, Diagnostics and Drug Discovery. Startups operating in these areas may find Therese Liechtenstein relevant.
4BIO Capital appears in Seed, Series A and Series B rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Therese Liechtenstein is worth approaching.
Colleagues at 4BIO Capital
Dima Kuzmin
Managing Partner
London, United Kingdom
Brian McVeigh
Venture Partner
Philadelphia, United States
Kieran Mudryy
Partner
Singapore
Owen Smith
Partner
United Kingdom
Natalie Johnston
Principal
London, United Kingdom
Andrew Kozlov
Managing Partner
Zürich, Switzerland
Frequently asked questions
Who is Therese Liechtenstein?
Therese Liechtenstein is a venture capital investor based in Germany, listed as Investment Director at 4BIO Capital. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to Therese Liechtenstein personally.
What does Therese Liechtenstein invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cellular Therapy, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Therese Liechtenstein invest at?
4BIO Capital appears in Seed, Series A and Series B rounds across its known deals, and Therese Liechtenstein is listed there as Investment Director. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Therese Liechtenstein listed at?
Therese Liechtenstein is listed as Investment Director at 4BIO Capital. 6 other people in the database share a firm with Therese Liechtenstein.
How do I contact Therese Liechtenstein?
A LinkedIn page is on file for Therese Liechtenstein. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal